CIK 0002022416 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Shirvan Mitchell CSO and CDO | Grant or award | +6,000 | 8,789 | ||
| 2026-06-04 | Horenshtein Hadar Mirit CFO and Secretary | Grant or award | +7,500 | 12,515 | ||
| 2026-06-04 | Hadar Ilan Chairman and CEO | Grant or award | +10,000 | 16,547 | ||
| 2026-03-26 | Shirvan Mitchell CSO and CDO | Sale | −22,818 | $1.36 | $31K | 27,889 |
| 2026-02-20 | Noy Shlomo Director | Grant or award | +9,091 | 25,399 | ||
| 2026-02-20 | Noy Shlomo Director | Grant or award · Stock Option (right to buy ordinary shares) | +10,685 | 10,685 | ||
| 2026-02-20 | Alon Ruth Director | Grant or award | +9,091 | 10,228 | ||
| 2026-02-20 | Alon Ruth Director | Grant or award · Stock Option (right to buy Ordinary Shares) | +10,685 | 10,685 | ||
| 2026-02-20 | Shirvan Mitchell CSO and CDO | Grant or award | +49,726 | 50,707 | ||
| 2026-02-20 | Horenshtein Hadar Mirit CFO and Secretary | Grant or award | +49,726 | 50,146 | ||
| 2026-02-20 | Hadar Ilan Chairman and CEO | Grant or award | +64,350 | 65,471 | ||
| 2026-02-20 | Abramov Dror Yosef Director | Grant or award | +9,091 | 10,180 | ||
| 2026-02-20 | Abramov Dror Yosef Director | Grant or award · Stock Option (right to buy ordinary shares) | +10,685 | 10,685 | ||
| 2026-02-20 | Peled Amnon Director | Grant or award | +7,576 | 8,237 | ||
| 2026-02-20 | Peled Amnon Director | Grant or award · Stock Option (right to buy Ordinary Shares) | +8,904 | 8,904 | ||
| 2026-02-20 | Lushi Avner Director | Grant or award | +9,091 | 25,399 | ||
| 2026-02-20 | Lushi Avner Director | Grant or award · Stock Option (right to buy ordinary shares) | +10,685 | 10,685 | ||
| 2025-09-15 | Levin Ilan Director | Grant or award | +450,000 | $4.00 | $1.8M | 456,970 |
| 2025-08-07 | Levin Ilan Director | Other disposition | −5,550 | 6,970 | ||
| 2025-08-07 | Levin Ilan Director | Other disposition · Warrant (right to buy) | −935 | 372 |
Page 1 of 2 · 30 trades